Related references
Note: Only part of the references are listed.Crystal Engineering of Stable Temozolomide Cocrystals
N. Jagadeesh Babu et al.
CHEMISTRY-AN ASIAN JOURNAL (2012)
Polymorphs and a Hydrate of Furosemide-Nicotinamide 1:1 Cocrystal
Takamitsu Ueto et al.
CRYSTAL GROWTH & DESIGN (2012)
Polymorphic Anhydrous Cocrystals of Gallic Acid and Acetamide from Methanol: Pointers toward a Stable Cocrystal Form
Ramanpreet Kaur et al.
CRYSTAL GROWTH & DESIGN (2012)
Polymorphism and phase transformations of a cocrystal of nicotinamide and pimelic acid
Srinivasulu Aitipamula et al.
CRYSTENGCOMM (2012)
Polymorphic supramolecular organic fluorophore composed of 2-naphthalenecarboxylic acid and benzylamine
Yuhei Kobayashi et al.
CRYSTENGCOMM (2012)
Fast dissolving eutectic compositions of two anti-tubercular drugs
Suryanarayan Cherukuvada et al.
CRYSTENGCOMM (2012)
Synthon polymorphism and pseudopolymorphism in co-crystals. The 4,4 '-bipyridine-4-hydroxybenzoic acid structural landscape
Arijit Mukherjee et al.
CHEMICAL COMMUNICATIONS (2011)
Co-Crystals of Sulfamethazine with Some Carboxylic Acids and Amides: Co-Former Assisted Tautomerism in an Active Pharmaceutical Ingredient and Hydrogen Bond Competition Study
Soumyajit Ghosh et al.
CRYSTAL GROWTH & DESIGN (2011)
Pyrazinamide-Diflunisal: A New Dual-Drug Co-Crystal
Antonio O. L. Evora et al.
CRYSTAL GROWTH & DESIGN (2011)
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
N. Jagadeesh Babu et al.
CRYSTAL GROWTH & DESIGN (2011)
Conformational polymorphism of the molecular complex of 3-fluorobenzoic acid with 4-acetylpyridine
Lynne H. Thomas et al.
CRYSTENGCOMM (2011)
Drug-drug co-crystals: Temperature-dependent proton mobility in the molecular complex of isoniazid with 4-aminosalicylic acid
Pawel Grobelny et al.
CRYSTENGCOMM (2011)
Solvates and polymorphic phase transformations of 2-chloro-4-nitrobenzoic acid
Srinivasulu Aitipamula et al.
CRYSTENGCOMM (2011)
Coformer Selection in Pharmaceutical Cocrystal Development: a Case Study of a Meloxicam Aspirin Cocrystal That Exhibits Enhanced Solubility and Pharmacokinetics
Miranda L. Cheney et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The cocrystal of 4-oxopimelic acid and 4,4 '-bipyridine: polymorphism and solid-state transformations
Ivan Halasz et al.
NEW JOURNAL OF CHEMISTRY (2011)
Ethenzamide-gentisic acid-acetic acid (2/1/1)
Srinivasulu Aitipamula et al.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE (2010)
Polymorphs and Solvates of a Cocrystal Involving an Analgesic Drug, Ethenzamide, and 3,5-Dinitrobenzoic Acid
Srinivasulu Aitipamula et al.
CRYSTAL GROWTH & DESIGN (2010)
Conformational and enantiotropic polymorphism of a 1: 1 cocrystal involving ethenzamide and ethylmalonic acid
Srinivasulu Aitipamula et al.
CRYSTENGCOMM (2010)
Molecular Complexes of Alprazolam with Carboxylic Acids, Boric Acid, Boronic Acids, and Phenols. Evaluation of Supramolecular Heterosynthons Mediated by a Triazole Ring
Sunil Varughese et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Synthesis and Preliminary Characterization of Sulfamethazine-Theophylline Co-Crystal
Jie Lu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Synthesis, Characterization, and Molecular Modeling of a Pharmaceutical Co-Crystal: (2-Chloro-4-Nitrobenzoic Acid):(Nicotinamide)
Andreas Lemmerer et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Herringbone array of hydrogen-bonded ribbons in 2-ethoxybenzamide from high-resolution X-ray powder diffraction
Silvina Pagola et al.
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2009)
Improving Mechanical Properties of Crystalline Solids by Cocrystal Formation: New Compressible Forms of Paracetamol
Shyam Karki et al.
ADVANCED MATERIALS (2009)
Analysis of 50 Crystal Structures Containing Carbamazepine Using the Materials Module of Mercury CSD
Scott L. Childs et al.
CRYSTAL GROWTH & DESIGN (2009)
Co-Crystals of the Anti-HIV Drugs Lamivudine and Zidovudine
Prashant M. Bhatt et al.
CRYSTAL GROWTH & DESIGN (2009)
Pharmaceutical Cocrystals and Their Physicochemical Properties
Nate Schultheiss et al.
CRYSTAL GROWTH & DESIGN (2009)
Trimorphs of a pharmaceutical cocrystal involving two active pharmaceutical ingredients: potential relevance to combination drugs
Srinivasulu Aitipamula et al.
CRYSTENGCOMM (2009)
Dimorphs of a 1:1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph
Srinivasulu Aitipamula et al.
CRYSTENGCOMM (2009)
Polymorphs and polymorphic cocrystals of temozolomide
N. Jagadeesh Babu et al.
CHEMISTRY-AN ASIAN JOURNAL (2008)
The study of the polymorphic system of 2-chloro-4-nitrobenzoic acid
Inna Barsky et al.
NEW JOURNAL OF CHEMISTRY (2008)
Performance comparison of a co-crystal of carbamazepine with marketed product
Magali B. Hickey et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Amide-N-oxide heterosynthon and amide dimer homosynthon in cocrystals of carboxamide drugs and pyridine N-oxides
N. Jagadeesh Babu et al.
MOLECULAR PHARMACEUTICS (2007)
Sulfa drugs as model cocrystal formers
Mino R. Caira
MOLECULAR PHARMACEUTICS (2007)
Pharmaceutical cocrystal and salts of norfloxacin
Srinivas Basavoju et al.
CRYSTAL GROWTH & DESIGN (2006)
Pharmaceutical cocrystals: An emerging approach to physical property enhancement
William Jones et al.
MRS BULLETIN (2006)
Physical stability enhancement of theophylline via cocrystallization
Andrew V. Trask et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Preparation and solid-state characterization of nonstoichiometric cocrystals off a phosphodiesterase-IV inhibitor annul L-tartaric acid
N Variankaval et al.
CRYSTAL GROWTH & DESIGN (2006)
2-carbamoyl-3-nitrobenzoic acid
Xue-Mei Li et al.
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS (2006)
Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid
P Delaquis et al.
JOURNAL OF FOOD PROTECTION (2005)
Experimental and theoretical IR, Raman, NMR spectra of 2-, 3- and 4-aminobenzoic acids
M Samsonowicz et al.
JOURNAL OF MOLECULAR STRUCTURE (2005)
Pharmaceutical cocrystallization: Engineering a remedy for caffeine hydration
AV Trask et al.
CRYSTAL GROWTH & DESIGN (2005)
Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities
A Glomme et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients
P Vishweshwar et al.
CHEMICAL COMMUNICATIONS (2005)
High-throughput crystallization:: polymorphs, salts, co-crystals and solvates of phan-naceutical solids
SL Monissette et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
O Almarsson et al.
CHEMICAL COMMUNICATIONS (2004)
Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine
SG Fleischman et al.
CRYSTAL GROWTH & DESIGN (2003)
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids
JF Remenar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Crystal engineering of the composition of pharmaceutical phases
RDB Walsh et al.
CHEMICAL COMMUNICATIONS (2003)
Preparation of solid dispersion for ethenzamide-carbopol and theophylline-carbopol systems using a twin screw extruder
M Ozawa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2002)